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Nutritional benefits of walnut are well known; however, currently, there is no research showing that walnut can be used 
as an antioxidant in people with diabetes mellitus (DM). Therefore, the objective of this study was to investigate the 
protective effects of walnut against oxidative stress in hepatic ischemia-reperfusion (I/R) injury in streptozotocin (STZ) 
induced diabetic rats. Animals were divided into four-groups (Control, DM, DM+I/R, DM+I/R+Walnut; n=6 each). STZ 
treatment and I/R procedures were not performed in the control group, other groups were first administered 60-mg/kg STZ 
intraperitoneally. After 48-h, animals were considered as DM. After four-weeks, DM groups were subjected to 30 min of 
hepatic-ischemia followed by 45-min reperfusion. DM+I/R+Walnut group was fed pellet-feed mixed with walnut  
 (2 g/100 g/day) until I/R. Other groups were fed only with pellet-feed. At the experimental end, animals decapacitated, 
blood samples collected to determine serum levels of tumor necrosis factor (TNF)-α, interleukin (IL)-6, malondialdehyde 
(MDA). Liver samples were collected for histological examinations. Forty-eight-hours after STZ, animals showed 
significant weight-loss compared to age-matched controls, blood glucose levels were increased (P< 0.05). Four-weeks post-
STZ, blood glucose also increased significantly. TNF-α, IL-6, MDA substantially increased in the DM+/I/R group  
(P< 0.01), whereas in DM+I/R+Walnut group this increase was lesser (P< 0.05). Aspartate aminotransferase, alanine 
aminotransferase, lactate dehydrogenase (LDH) levels were lower in DM+/I/R+Walnut vs. DM+I/R groups; but higher than 
DM/control groups (P< 0.05). Positive-correlation observed between TNF-α and IL-6 (Spearman r:0.793; P< 0.001), and 
moderately-positive-correlation between IL-6 and LDH (Spearman r:0.429; P< 0.05). Histopathology revealed disordered 
hepatic lobules, swelling cells, vacuoles in liver specimens visible in the DM+I/R group, implicating hepatic I/R injury, 
which improved in DM+I/R+Walnut specimens. We conclude that in diabetic rats, hepatic I/R injury is associated with 
augmented inflammatory response and oxidative stress, while walnut pre-treatment significantly decreased these responses. 
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Reduced perfusion due to any decrease or complete 
loss in blood supply to the organ or tissues is referred 
to as ‘ischemia’. Diminished oxygenation of the tissue 
due to ischemia for a certain period of time results in 
tissue damage or necrosis. Reconstruction of tissue 
blood supply after ischemia is called ‘reperfusion’. 
However, while meeting the oxygen and other 
metabolic needs of the tissue, paradoxically this 
condition causes much more damage in the tissues1,2, 
and this condition is called ‘ischemia reperfusion’ 
(I/R) injury. The tissue damage during the reperfusion 
period is especially caused by free oxygen derivatives 
such as reactive oxygen species (ROS) generated by 
the oxygen input into the cell, activation of 
polymorphonuclear leukocytes, and the effects of 
endothelial and complement systems3,4. Cellular 
structures that are most sensitive to reperfusion injury 
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are membrane lipids, proteins, nucleic acids, and 
deoxyribonucleic acid molecules5. 
The I/R injury is not limited to the region in which 
it occurs, but it can also cause varying degrees of 
damage to other organ systems. Although its 
mechanism has not been fully elucidated yet, in the 
I/R injury that takes place in organs (such as lung 
tissue, kidneys, liver, skeletal muscles, heart, and 
gastrointestinal tract), it has been shown that damage 
also occurs in distant organs6. The local and systemic 
effects caused by I/R injury contribute to high 
morbidity, and mortality in many clinical conditions 
such as organ transplantation, myocardial infarction, 
cerebrovascular diseases, major surgical 
interventions, thrombolytic therapy, hemorrhagic 
shock and resuscitation7,8. 
Diabetes mellitus (DM) is a chronic disease 
characterized by hyperglycemia and is primarily 
caused by insulin deficiency or resistance. In addition, 
DM is a metabolic disorder that is related to defects in 
carbohydrate, protein, and fat metabolism, and is 
usually accompanied by many severe complications 
such as retinopathy, nephropathy, and neuropathy9,10. 
It is also associated with several metabolic 
abnormalities such as elevated free fatty acid levels, 
increased advanced glycation end-products, and 
augmented superoxide anion productions, which are 
major factors concerned in the pathogenesis of 
diabetic complications11. 
Elevated glucose levels provoke non-enzymatic 
and auto-oxidative glycosylation, promote protein 
kinase-C activation, which leads to alterations in the 
levels of inflammatory mediators12. In previous 
experimental studies, oxidative stress produced by 
high glucose levels has been described as a reason for 
diabetic inflammation13,14. DM induces oxidative 
stress and augments the inflammatory response 
stimulated by I/R injury. Oxidative stress and ROS 
are the key factors in the pathogenesis of diabetic 
complications15. 
Walnut (Juglans regia L.) is a foodstuff that is of 
high importance because of its nutritional value and 
its positive effects on human health. It contains oils; 
72% consists of polyunsaturated fatty acids (59% 
linoleic, 13% α-linoleic), 18% monounsaturated fatty 
acids (oleic acid), and only 10% saturated fatty 
acids16. It is rich in multiple fatty acids, especially in 
Omega-3. These polyunsaturated fatty acids in the 
walnut were defined to prevent cardiovascular 
diseases, by virtue of having anti-inflammatory and 
anti-hypertensive effects, especially by decreasing the 
blood fat levels and preventing thrombosis and 
vascular occlusions17,18. Walnut consumption 
increases the level of melatonin hormone, which is an 
antioxidant and determines the biological rhythm, as 
Reither et al.10 reported that owing to the antioxidant 
content of walnut, it may have the ability to reduce 
the risk of cancer development, cardiovascular 
diseases, and/or neurological diseases such as 
Parkinson's disease and Alzheimer's disease19.  
Although there are several studies in the peer-
reviewed literature about the nutritional benefits of 
walnut, currently there is no research showing that 
walnut can be used as an antioxidant in people with 
DM. Therefore, in this study, we aimed to investigate 
the anti-inflammatory and antioxidant effects of 
walnut on ischemia-reperfusion injury in diabetic rats 
and evaluate its protective effects on liver 
parenchyma. 
 
Materials and Methods 
 
Animals 
In this study, 24 male Sprague-Dawley albino rats 
weighing 250-300 g were used. Rats were housed in a 
room at a constant temperature of +22°C, with 12-h 
light/dark cycles, and fed on standard pellet chow and 
water ad libitum. The animals were obtained from the 
Laboratory of Animal Care Division of the School of 
Medicine at Marmara University, Istanbul, Turkey. 
Experiments were performed according to the 
international ethical standards and approved by the 
Ethics Committee (Animal Care and Use Committee) 




Rats (n=24) were equally divided into four groups 
(n=6 each) as follows: Control group (C), Diabetes 
mellitus group (DM), Diabetes mellitus + 
Ischemia/Reperfusion group (DM+I/R), and Diabetes 
+ Ischemia/Reperfusion + Walnut group 
(DM+I/R+Walnut). Streptozotocin (STZ) treatment 
and ischemia-reperfusion procedure were not 
performed in the control group. The other three 
groups were first administered 60 mg/kg STZ 
intraperitoneally (IP; Sigma-Aldrich, St. Louis, MO, 
USA) to create a diabetes model. The body weight 
was measured using Precision Scales (Northglenn, 
CO, USA). After 48 h, the blood glucose levels of all 
these rats reached over 200 mg/dL, and were 




considered as diabetic. Blood glucose levels were 
measured using ACCU-CHEK® Performa glucometer 
(Amicadeal, Inc., Federal Way, WA, USA). An 
ischemia-reperfusion model was developed after four-
weeks of waiting for the development of chronic 
diabetes. The DM+I/R+Walnut group was fed with 
pellet feed mixed with walnut (2 g/100 g/day) until 
ischemia reperfusion. All other groups were fed only 
with pellet feed. In the fourth week, the rats were 
given 100 mg/kg ketamine for anesthesia. After 
laparotomy with a midline incision, a 30 min ischemia 
was created by clamping the vena porta and the 
hepatic artery. Tissue samples were taken from the 
liver and blood was drawn from the vena cava 
inferior, 45 min after the reperfusion was achieved. 
The hepatic tissue samples were placed in 
formaldehyde (10%) for histological evaluations. 
Serum samples thus obtained after centrifugation of 
blood were stored at −80C until further use. 
 
Biochemical analyses 
Serum malondialdehyde (MDA) levels were 
measured spectrophotometrically by using the 
thiobarbituric acid reactive substance (TBARS) 
method. To assess the serum levels of tumor necrosis 
factor-α (TNF-α) and IL-6, double sandwich enzyme-
linked immune sorbent assay (ELISA) kits were used 
(R&D Systems, Minneapolis, MN, USA). Serum 
levels of aspartate aminotransferase (AST), alanine 
aminotransferase (ALT), and lactate dehydrogenase 
(LDH) were analyzed utilizing diagnostic kits (BD 
Biosciences, Franklin Lakes, NJ, USA) and using 
automated biochemical equipment (Abbott C8000; 
Abbott Laboratories, Chicago, IL, USA).  
 
Histopathological evaluations  
Tissue specimens were fixed in 10% formaldehyde 
and then embedded in paraffin blocks. The paraffin 
sections (4-5 μm) were stained with hematoxylin & 
eosin (H&E) and examined under a photomicroscope 
(Olympus BX51, Tokyo, Japan) by the qualified-
independent histologist in a blinded manner. 
 
Statistical analyses 
SPSS statistics 25 software (IBM Corp., Chicago, IL, 
USA), MedCalc version 15.8 software, and InStat3 
GraphPad software were used for all statistical analyses. 
Kruskal-Wallis test (nonparametric ANOVA) and Post-
hoc test (Dunn’s Multiple Comparison test) were used to 
compare nonparametric data in the independent groups 
with more than two groups (since the number of subjects 
in each group was <30). Correlation Matrix analysis and 
Spearman correlation analysis in nonparametric data 





Body weight and blood glucose level 
The bodyweight and blood glucose levels were 
measured at the beginning and 48 h after STZ 
injection and were found to be similar at the 
beginning of the study among all the groups. Forty-
eight hours after the STZ injection, animals showed a 
significant weight loss compared to the age-matched 
controls, and the average blood glucose levels were 
significantly increased. And 4-weeks after the STZ 
injection, the average blood glucose levels were found 
to be significantly increased (Table 1). 
 
Serum TNF-α levels  
Results obtained from the determination of TNF-α 
levels of the experimental groups are shown in  
(Table 2 & Fig. 1). TNF-α levels in the DM+I/R+ 
Walnut group of animals were found to be 
significantly lower than the DM and/or DM+I/R 
groups (P< 0.05). There was no significant difference 
in TNF-α levels between the DM+I/R+Walnut and 
control groups (P> 0.05). Although TNF-α levels 
were relatively higher in the DM group as compared 
to DM+I/R group, the difference was not statistically 
significant (P> 0.05) (Fig. 1 & Table 2). 
 
Serum IL-6 levels 
As shown in (Table 2 & Fig. 1), serum IL-6  
levels in the DM+I/R+Walnut group were found to  
be significantly lower than in both the DM and 
Table 1 — Body weight and blood glucose levels in various 
groups of rat specimen 
Animal 
Groups 
Body Weight (g)  Blood Glucose (mg/dL) 
 Initial 48 h  
Later 














































Vales are expressed as means ± standard errors of mean (SEM) 
(n=6 rats in each group) 
a,b,c P< 0.001compared to I0 




DM+I/R groups (P< 0.05). However, the IL-6 levels 
of the DM+I/R group were significantly higher  
than in the control group (P< 0.05). Notably, there 
was no statistical difference in the IL-6 levels 
between the DM+I/R+Walnut and control groups  
(P> 0.05). 
 
Serum MDA levels 
The MDA levels in various experimental groups 
were examined and the results thus obtained are 
shown in (Table 2 and Fig. 1). The MDA levels in  
the DM+I/R+Walnut group of specimens were 
significantly lower than the DM and/or DM+I/R 
groups (P< 0.05). There was no significant difference 
in the levels of MDA between the DM+I/R+ 
Walnut and control groups (P> 0.05). Although the 
MDA levels of DM+I/R group were relatively higher 
than the DM group of rats, the difference was not 
found to be statistically significant (P> 0.05). 
 
Serum levels of AST, ALT, and LDH  
The serum levels of AST, ALT, and LDH were 
found to be significantly lower in the DM+/I/R 
+Walnut group as compared to the DM+I/R group; 
but higher than the DM and control groups of animals 
(P< 0.05) (Fig. 2 and Table 2). 
 
Correlation investigations 
According to the correlation matrix assessments, 
there was a statistically significant good and 
moderately positive correlation between the TNF-α, 
 
Table 2 — Determination of the levels of biochemical parameters and its comparison between the experimental groups 
 Control (n=6) DM (n=6) DM+IR (n=6) DM+I/R+Walnut (n=6) P-Value 
TNF-α (pg/mL) 169 ± 30 
165 (138-222) 
361 ± 73 
345 (279-481) 
456 ± 249 
346 (257-877) 
161 ± 8 
162 (152-171) 
a0.0006 
IL-6 (pg/mL) 5.16 ± 0.46 
5.1 (4.4-5.6) 
8.44 ± 1.18 
8.0 (7.7-10.8) 
10.56 ± 1.63 
10.7 (8.6-12.3) 
4.48 ± 0.79 
4.35 (3.58-5.7) 
a0.0002 
MDA (nmol/mL) 1.22 ± 0.21 
1.15 (1.0-1.5) 
1.51 ± 0.46 
1.15 (1.2-2.4) 
2.1 ± 0.27 
1.83 (0.9-1.9) 
1.37 ± 0.67 
1.3 (0.7-2.6) 
a0.0340 
AST (IU/L) 113 ± 10 
114 (101-125) 
154 ± 14 
151 (138-173) 
491 ± 18.1 
410 (378-499) 
362 ± 19.8 
129 (92-182) 
a0.0010 
ALT (IU/L) 47 ± 43 
43 (21-55) 
85 ± 16 
83 (90-103) 
133 ± 9 
124 (114-149) 
95 ± 5 
90 (78-108) 
a0.0398 
LDH (IU/L) 1,450 ± 455 
1,350 (1,193-1,838) 
1,499 ± 329 
1,327 (1,239-1,929) 
2,448 ± 376 
2,232 (1,975-2,827) 
1,587 ± 743 
1,264 (957-2,924) 
a0.0283 
aP-Value from Kruskal-Wallis test (non-parametric ANOVA) and Post-hoc test (Dunn’s Multiple Comparison test). If the 
P-value obtained by ANOVA test was found to be <0.05, multiple comparison tests were performed to determine the P-value between 
the groups (as also shown in Figs. 1 & 2). For each panel, upper values are Mean ± SD and the lower values are Median





Fig. 1 — Results on the mean serum values of biochemical parameters (TNF-α, IL-6, MDA levels) in all the experimental groups 
of rats 
 




IL-6, and LDH levels. There was also a moderately 
positive correlation between the IL-6, AST, and  
LDH levels (Table 3). According to the data  
obtained through Spearman analysis, there was a 
statistically significant and positive correlation 
between the TNF-α and IL-6 levels (Spearman  
r: 0.793; P< 0.001) (Fig. 3A). There was also  
a moderately positive correlation between the  




Hepatic cells and hepatic microvascular injury 
were investigated by light microscopy. Utilizing H&E 
staining, we observed that disordered hepatic lobules, 
swelling cells and vacuoles in the liver specimens 
were visible in the DM+I/R group, which implied that 
the hepatic I/R injury did occur. The phenomenon 
seems to be improved in the DM+I/R+Walnut group 
of specimens (Fig. 4). 
Discussion 
This study demonstrates that the serum TNF-α,  
IL-6, and MDA levels increased in diabetic rats  
with hepatic ischemia-reperfusion damage (DM+I/R 









Fig. 3 — (A) Spearman correlation analysis between TNF-α and LDH and IL-6 levels. A positive correlation was found between 
TNF-α and IL-6 levels; and (B) Spearman correlation analysis between IL-6 and AST and LDH levels. A moderate positive correlation
was found between IL-6 and LDH levels 
Table 3 — Correlation Matrix results in order to observe 
the degree of correlation between serum levels of various 
biochemical parameters in different experimental groups 
of rats 
r TNF-α IL-6 MDA AST LDH ALT 
TNF-α 1.0000 0.7773 −0.0732 0.1409 0.3973 0.1277
IL-6 0.7773 1.0000 0.1358 0.3945 0.4231 0.2246
MDA −0.0732 0.1358 1.0000 0.0294 0.1348 0.3323
AST 0.1409 0.3945 0.0294 1.0000 −0.1497 0.1417
LDH 0.3973 0.4231 0.1348 −0.1497 1.0000 0.2488
ALT 0.1277 0.2246 0.3323 0.1417 0.2488 1.0000
Each correlation coefficient (r) was calculated independently 
regardless of other variables. Results with r < 0.20 are considered 
statistically insignificant 




(DM+I/R+Walnut group), the increased level was 
relatively lesser. These results are also supported by 
histopathological findings and biochemical test results 
on AST, ALT, and LDH levels in that walnut 
prevented the alterations which take place due to 
oxidative stress in diabetic rats. 
Diabetes mellitus is one of the diseases that cause 
the highest mortality and morbidity in the world. 
Microvascular and macrovascular complications such 
as diabetic retinopathy, diabetic nephropathy, diabetic 
neuropathy, ischemic heart disease, stroke, and 
atherosclerosis are frequently seen in these patients. 
Oxidative stress plays important role in the emergence 
of these complications20. Oxidative stress is primarily 
caused by the increase of ROS and/or reactive nitrogen 
species (RNS) in the organism21. The possible sources 
of oxidative stress in diabetes are the auto-oxidation of 
glucose, shifts in redox equilibrium, decreased tissue 
concentrations of antioxidants or reduced glutathione, 
or inadequate activity of antioxidant enzymes such as 
superoxide dismutase (SOD) or catalase (CAT)22,23. 
The ROS produced after the I/R injury stimulates 
the release of pro-inflammatory cytokines thereby 
activating macrophages. Pro-inflammatory cytokines 
such as TNF-α and IL-6 play important role(s) in both 
the local and distant organ damage, causing the 
activation of polymorphonuclear leukocytes24. In our 
study, we found that inflammatory TNF-α and IL-6 
levels were increased in hepatic I/R developed 
diabetic rats and this increase was accompanied  
by tissue damage. We also showed this finding  
with substantial elevation in the biochemical markers 
of hepatic tissue damage (such as AST, ALT, and 
LDH) and with the correlation determined between 
TNF-α, IL-6, LDH, and AST levels. Additionally, 
histopathological examination of liver tissue of the 
I/R rats showed tissue damage. Notably, when hepatic 
I/R developed in the walnut-fed diabetic rats, we 
observed that this inflammatory response and tissue 
damage were relatively lesser. 
One of the most important target structures of the 
ROS that occurs when the organism develops I/R are 
 
 
Fig. 4 — Representative H&E stains of rat hepatic tissues (A) Control group sample with normal hepatic tissue structure (H&E; ×40); 
(B) DM group sample with inflammatory cell infiltration and vacuolization sinus dilatation in the liver (H&E; ×40); (C) DM+I/R
group sample with disordered hepatic lobules, swelling cells and vacuoles in the liver specimens were visible (H&E; ×40); and
(D) Diabetic and hepatic I/R+Walnut group sample with minimal cell infiltration (H&E; ×40) 
 




the lipids, and the lipid peroxidation is accepted as the 
key to I/R injury by some researchers25. Free oxygen 
radicals initiate lipid peroxidation by taking a 
hydrogen atom from polyunsaturated fatty acids, 
resulting in the formation of hydroperoxides. As a 
result of these reactions, the cell membrane loses its 
fluidity and the membrane integrity deteriorates, 
which leads to the release of cell fractions into the 
environment and cell death. On the other hand, these 
subcellular structures released into the environment 
trigger inflammatory events and worsen the damage. 
Malondialdehyde measurement is one of the most 
common indicators of lipid peroxidation in tissue, and 
in our study, we found that the MDA levels increased 
in the hepatic I/R developed diabetic rats and walnut 
nourishment prevented this increase. 
Some enzymatic and non-enzymatic natural 
antioxidants protect the organism against oxidative stress. 
Among those, non-enzymatic antioxidants include A, C, 
E, B1, B2, B12 vitamins, glutathione, alpha lipoic acid, 
carotenoids, coenzyme Q10, bioflavonoids, some 
minerals (e.g., copper, zinc, manganese, and selenium), 
folic acid, uric acid, and albumin. The enzymatic 
antioxidants are SOD, CAT, glutathione peroxidase 
(GSH-PX), and glutathione reductase (GSH-RD)26. 
Under normal physiological conditions, antioxidants 
affect signal transduction, immune response, and 
regulation of cell proliferation. Various antioxidants can 
be used in the treatment and prevention of cancer, 
diabetic complications, and cardiovascular diseases 
caused by ROS27. 
Walnut (Juglans regia L.) is a food stuff (a functional 
food) with many positive effects on health28-32. Walnuts 
contains protein (13.6 - 22.3%), fat (56.4 - 70.6%), and 
ash (2%). Its fat content is consists of 72% of 
polyunsaturated fatty acid (PUFA, 59% linoleic, 13% 
α-linoleic), 18% monounsaturated fatty acid (MUFA; 
oleic acid), and 10% saturated fatty acids17. Walnut 
contains a high percentage of PUFA and Omega-3 fatty 
acids. Containing both n-6 and n-3 PUFA together is a 
very important feature of walnut33. In addition, it 
contains numerous antioxidants and minerals such as 
vitamins A, C, E, B1, B2, folic acid, pantothenic acid, 
niacin, iron, zinc, copper, magnesium, and phosphorus. 
Walnut includes δ-tocopherol, phytosterol, and 
polyphenols, which are also antioxidants and increase 
the importance of walnut. Furthermore, the presence of 
melatonin in walnut structure with antioxidant 
properties and beneficial effects on the cardiovascular 
system has been found34. Considering all these points, 
walnut is a miraculous antioxidant store, and in our 
study, the lower I/R damage in the diabetic rats fed 
with walnuts, the lower TNF-α, IL-6, and MDA levels 
proved that walnut is a very powerful antioxidant. 
As with any biomedical study, there are some 
potential limitations that are worth mentioning. First, 
this is an experimental study carrying all potential 
bias associated with the differences in metabolisms of 
rats and humans. Second, it would have been better if 
we could have measured the MDA and glutathione 
levels in the tissue specimens of various experimental 
groups, which we could not do due to limited 
resources. 
Thus, we demonstrate that in diabetic rats, hepatic 
I/R injury is associated with an augmented 
inflammatory response and oxidative stress, while 
walnut pre-treatment significantly decreased these 
responses. Diabetes mellitus is a rapidly growing 
disease with high morbidity and mortality worldwide, 
as there are many vascular complications related to 
oxidative stress in diabetic patients. We suggest that 
the walnut can be considered as a miraculous 
antioxidant depot and should be involved in the 
nutrition and treatment of these patients. We believe 
that it is important to perform more translational 
research studies in this exciting area to gain better 
clinical outcomes for patients with diabetes. 
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